{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:56:44Z","timestamp":1781650604479,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515110438"],"award-info":[{"award-number":["2022A1515110438"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012899"],"award-info":[{"award-number":["2024A1515012899"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170617"],"award-info":[{"award-number":["32170617"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370649"],"award-info":[{"award-number":["32370649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302078"],"award-info":[{"award-number":["82302078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project of Guangzhou, China","award":["202002020010"],"award-info":[{"award-number":["202002020010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      X-linked hypophosphatemic rickets (XLH, OMIM: 307800) is the most prevalent hereditary ricket characterized by hypophosphatemia, rickets, and osteomalacia. XLH resulted from pathogenic variants in\n                      <jats:italic>PHEX<\/jats:italic>\n                      gene. Patients with XLH may experience symptoms that begin in childhood and persist into adulthood or even throughout life, significantly impacting their quality of life. Therefore, studying the genetic etiology and pathogenic mechanisms of XLH is fundamental for the prevention, diagnosis, and treatment of the disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified a novel pathogenic variant in\n                      <jats:italic>PHEX<\/jats:italic>\n                      within XLH families: c.1814delC p.Thr605MetfsTer14. This variant has not been previously reported in patients with XLH. In in vitro functional studies, the variant (c.1814delC p.Thr605MetfsTer14) reduced the protein expression and stability of PHEX and altered its localization. Furthermore, the overexpression of wild-type PHEX inhibited mineralization in contrast to the control group. The PHEX variant (p.Thr605MetfsTer14) exhibited a greater capacity to promote mineralization than the wild-type group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We propose a potential correlation between reduced protein degradation rate and XLH phenotypes. The PHEX variant protein (p.Thr605MetfsTer14) changed the protein structure, induced mislocalization, accelerated protein degradation, and finally caused a decrease in protein expression, which affected mineralization. Our findings provide valuable data on XLH pathogenesis and genotype-phenotype correlations. The expression and mineralization studies of the PHEX variant offer important insights into the pathogenesis of XLH disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04354-x","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:47:44Z","timestamp":1776516464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The PHEX deletion variant (p.Thr605MetfsTer14) causes X-linked hypophosphatemic rickets by reducing protein expression and promoting mineralization"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhongzhi","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-6165","authenticated-orcid":false,"given":"Fu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"6","key":"4354_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","volume":"18","author":"A Trombetti","year":"2022","unstructured":"Trombetti A, Al-Daghri N, Brandi ML, Cannata-Andia JB, Cavalier E, Chandran M, et al. Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia. Nat Reviews Endocrinol. 2022;18(6):366\u201384.","journal-title":"Nat Reviews Endocrinol"},{"key":"4354_CR2","doi-asserted-by":"crossref","unstructured":"Fuente R, Garcia-Bengoa M, Fernandez-Iglesias A, Gil-Pena H, Santos F, Lopez JM. Cellular and molecular alterations underlying abnormal bone growth in X-linked hypophosphatemia. Int J Mol Sci. 2022;23(2).","DOI":"10.3390\/ijms23020934"},{"key":"4354_CR3","doi-asserted-by":"publisher","first-page":"153892","DOI":"10.1016\/j.metabol.2019.03.009","volume":"103S","author":"A Rothenbuhler","year":"2020","unstructured":"Rothenbuhler A, Schnabel D, Hogler W, Linglart A. Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH). Metabolism-Clinical Experimental. 2020;103S:153892.","journal-title":"Metabolism-Clinical Experimental"},{"issue":"7","key":"4354_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019;15(7):435\u201355.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"4354_CR5","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00198-021-05875-w","volume":"32","author":"M Jimenez","year":"2021","unstructured":"Jimenez M, Ivanovic-Zuvic D, Loureiro C, Carvajal CA, Cavada G, Schneider P, et al. Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia. Osteoporos Int. 2021;32(9):1825\u201336.","journal-title":"Osteoporos Int"},{"issue":"1","key":"4354_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13023-020-01434-4","volume":"15","author":"R Padidela","year":"2020","unstructured":"Padidela R, Nilsson O, Makitie O, Beck-Nielsen S, Ariceta G, Schnabel D, et al. The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study. Orphanet J Rare Dis. 2020;15(1):172.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4354_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-021-02156-x","volume":"17","author":"FH Glorieux","year":"2022","unstructured":"Glorieux FH, Bonewald LF, Harvey NC, van der Meulen M. Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH). Orphanet J Rare Dis. 2022;17(1):30.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4354_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11154-017-9408-1","volume":"18","author":"R Fuente","year":"2017","unstructured":"Fuente R, Gil-Pena H, Claramunt-Taberner D, Hernandez O, Fernandez-Iglesias A, Alonso-Duran L, et al. X-linked hypophosphatemia and growth. Rev Endocr Metab Disord. 2017;18(1):107\u201315.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"4354_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/hmg\/6.4.539","volume":"6","author":"PS Rowe","year":"1997","unstructured":"Rowe PS, Oudet CL, Francis F, Sinding C, Pannetier S, Econs MJ, et al. Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet. 1997;6(4):539\u201349.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4354_CR10","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/jbmr.3955","volume":"35","author":"PS Smith","year":"2020","unstructured":"Smith PS, Gottesman GS, Zhang F, Cook F, Ramirez B, Wenkert D, et al. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3\u2019-UTR Mutation c.*231A\u2009>\u2009G (A Retrospective Case-Control Study). J Bone Miner Res. 2020;35(5):920\u201331.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"4354_CR11","doi-asserted-by":"publisher","first-page":"F783","DOI":"10.1152\/ajprenal.00304.2010","volume":"300","author":"V David","year":"2011","unstructured":"David V, Martin A, Hedge AM, Drezner MK, Rowe PS. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate. Am J Physiol Ren Physiol. 2011;300(3):F783\u201391.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"4354_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41368-023-00259-8","volume":"15","author":"DSE Lira","year":"2023","unstructured":"Lira DSE, Nakajima K, Po J, Hanai A, Zhukouskaya V, Biosse DM, et al. Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia. Int J Oral Sci. 2023;15(1):53.","journal-title":"Int J Oral Sci"},{"issue":"10","key":"4354_CR13","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/jbmr.3197","volume":"32","author":"K Johnson","year":"2017","unstructured":"Johnson K, Levine K, Sergi J, Chamoun J, Roach R, Vekich J, et al. Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption. J Bone Miner Res. 2017;32(10):2062\u201373.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"4354_CR14","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.2215\/CJN.05910809","volume":"5","author":"M Peacock","year":"2010","unstructured":"Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5(Suppl 1):S23\u201330.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"44","key":"4354_CR15","doi-asserted-by":"publisher","first-page":"j5018","DOI":"10.1126\/sciadv.abj5018","volume":"7","author":"VV Zhukouskaya","year":"2021","unstructured":"Zhukouskaya VV, Jauze L, Charles S, Leborgne C, Hilliquin S, Sadoine J, et al. A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia. Sci Adv. 2021;7(44):j5018.","journal-title":"Sci Adv"},{"issue":"2","key":"4354_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.24296","volume":"43","author":"S Sarafrazi","year":"2022","unstructured":"Sarafrazi S, Daugherty SC, Miller N, Boada P, Carpenter TO, Chunn L, et al. Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH). Hum Mutat. 2022;43(2):143\u201357.","journal-title":"Hum Mutat"},{"issue":"1","key":"4354_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1098-1004(200007)16:1<1::AID-HUMU1>3.0.CO;2-J","volume":"16","author":"Y Sabbagh","year":"2000","unstructured":"Sabbagh Y, Jones AO, Tenenhouse HS. PHEXdb, a locus-specific database for mutations causing X-linked hypophosphatemia. Hum Mutat. 2000;16(1):1\u20136.","journal-title":"Hum Mutat"},{"issue":"8","key":"4354_CR18","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1210\/jcem.86.8.7761","volume":"86","author":"IA Holm","year":"2001","unstructured":"Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, et al. Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 2001;86(8):3889\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4354_CR19","first-page":"879","volume":"40","author":"W Li","year":"2019","unstructured":"Li W, Tan L, Li X, Zhang X, Wu X, Chen H, et al. Identification of a p.Trp403* nonsense variant in PHEX causing X-linked hypophosphatemia by inhibiting p38 MAPK signaling. Hum Mutat. 2019;40(7):879\u201385.","journal-title":"Hum Mutat"},{"issue":"1","key":"4354_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41368-023-00252-1","volume":"15","author":"KA Carpenter","year":"2023","unstructured":"Carpenter KA, Alkhatib DO, Dulion BA, Guirado E, Patel S, Chen Y, et al. Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH). Int J Oral Sci. 2023;15(1):47.","journal-title":"Int J Oral Sci"},{"issue":"15","key":"4354_CR21","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/hmg\/10.15.1539","volume":"10","author":"Y Sabbagh","year":"2001","unstructured":"Sabbagh Y, Boileau G, DesGroseillers L, Tenenhouse HS. Disease-causing missense mutations in the PHEX gene interfere with membrane targeting of the recombinant protein. Hum Mol Genet. 2001;10(15):1539\u201346.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"4354_CR22","doi-asserted-by":"publisher","first-page":"e1262","DOI":"10.1002\/mgg3.1262","volume":"8","author":"B Li","year":"2020","unstructured":"Li B, Wang X, Hao X, Liu Y, Wang Y, Shan C, et al. A novel c.2179T\u2009>\u2009C mutation blocked the intracellular transport of PHEX protein and caused X-linked hypophosphatemic rickets in a Chinese family. Mol Genet Genomic Med. 2020;8(8):e1262.","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"4354_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.gene.2015.03.066","volume":"565","author":"Y Huang","year":"2015","unstructured":"Huang Y, Mei L, Pan Q, Tan H, Quan Y, Gui B, et al. Novel de novo nonsense mutation of the PHEX gene (p.Lys50Ter) in a Chinese patient with hypophosphatemic rickets. Gene. 2015;565(1):150\u20134.","journal-title":"Gene"},{"key":"4354_CR24","doi-asserted-by":"publisher","first-page":"116135","DOI":"10.1016\/j.bone.2021.116135","volume":"153","author":"Y Ishihara","year":"2021","unstructured":"Ishihara Y, Ohata Y, Takeyari S, Kitaoka T, Fujiwara M, Nakano Y, et al. Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling. Bone. 2021;153:116135.","journal-title":"Bone"},{"issue":"6","key":"4354_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41419-022-04969-5","volume":"13","author":"YM Gan","year":"2022","unstructured":"Gan YM, Zhang YP, Ruan DD, Huang JB, Zhu YB, Lin XF, et al. Function of PHEX mutations p.Glu145* and p.Trp749Arg in families with X-linked hypophosphatemic rickets by the negative regulation mechanism on FGF23 promoter transcription. Cell Death Dis. 2022;13(6):518.","journal-title":"Cell Death Dis"},{"issue":"8","key":"4354_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1302\/2046-3758.88.BJR-2018-0276.R1","volume":"8","author":"J Huang","year":"2019","unstructured":"Huang J, Bao X, Xia W, Zhu L, Zhang J, Ma J, et al. Functional analysis of a de novo mutation c.1692 del A of the PHEX gene in a Chinese family with X-linked hypophosphataemic rickets. Bone Joint Res. 2019;8(8):405\u201313.","journal-title":"Bone Joint Res"},{"issue":"1","key":"4354_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bone.2003.09.004","volume":"34","author":"ZQ Qiu","year":"2004","unstructured":"Qiu ZQ, Travers R, Rauch F, Glorieux FH, Scriver CR, Tenenhouse HS. Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice. Bone. 2004;34(1):134\u20139.","journal-title":"Bone"},{"issue":"2","key":"4354_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00223-013-9736-4","volume":"93","author":"S Ichikawa","year":"2013","unstructured":"Ichikawa S, Gray AK, Bikorimana E, Econs MJ. Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia. Calcif Tissue Int. 2013;93(2):155\u201362.","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"4354_CR29","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1074\/jbc.M107707200","volume":"277","author":"S Liu","year":"2002","unstructured":"Liu S, Guo R, Tu Q, Quarles LD. Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem. 2002;277(5):3686\u201397.","journal-title":"J Biol Chem"},{"issue":"7","key":"4354_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1359\/JBMR.050212","volume":"20","author":"RG Erben","year":"2005","unstructured":"Erben RG, Mayer D, Weber K, Jonsson K, Juppner H, Lanske B. Overexpression of human PHEX under the human beta-actin promoter does not fully rescue the Hyp mouse phenotype. J Bone Miner Res. 2005;20(7):1149\u201360.","journal-title":"J Bone Miner Res"},{"key":"4354_CR31","doi-asserted-by":"publisher","first-page":"117044","DOI":"10.1016\/j.bone.2024.117044","volume":"181","author":"T Nakanishi","year":"2024","unstructured":"Nakanishi T, Yamazaki M, Tachikawa K, Ueta A, Kawai M, Ozono K, et al. Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR\/Cas9-mediated gene ablation. Bone. 2024;181:117044.","journal-title":"Bone"},{"key":"4354_CR32","doi-asserted-by":"crossref","unstructured":"Liu ES, Martins JS, Zhang W, Demay MB. Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets. Development. 2018;145(15).","DOI":"10.1242\/dev.163519"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04354-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:21:36Z","timestamp":1781648496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04354-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4354"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04354-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Zhujiang Hospital of Southern Medical University in Guangzhou. The patients\/participants provided their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The consent for publication was obtained from the participants or their legal guardian. All patients\/participants agree to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}